In this randomised non-inferiority phase @ trial , done in seven radiotherapy centres in the Netherlands , we enrolled intermediate-risk or high-risk patients aged between @ and @ years with histologically confirmed stage T@b-T@ NX-@MX-@ prostate cancer , a PSA concentration of @ ng/mL or lower , and WHO performance status of @-@ .